Story
Pulse Biosciences Stock Surges on 'Buy' Rating, High Price Target
Shares of Pulse Biosciences (PLSE) surged in mid-day trading, climbing 8.3% against a backdrop of broader market declines. The rally was triggered after Freedom Capital Markets initiated coverage on the company with a "Buy" rating and a $73 price target.
Analyst Initiation Sparks Rally
The bullish call from Freedom Capital Markets analyst Keith Hinton is centered on the potential of Pulse Biosciences' proprietary nanosecond pulsed field ablation (nsPFA) technology. Hinton's analysis highlighted the atrial fibrillation ablation market as a large and growing sector ripe for disruption by the company's innovative approach.
The firm also noted that Pulse Biosciences' balance sheet is strong enough to support operations through its next major clinical data release. This financial stability is seen as a key factor in de-risking the path to its next milestone.
Focus on Clinical Trial and M&A Potential
The primary catalyst for the company is its ongoing NANOPULSE-AF clinical trial. Confidence in the study's timeline has been reinforced by the news that it has already surpassed its enrollment midpoint. The results from this trial are anticipated around the second quarter of 2027.
AdAccording to Freedom Capital, positive data from the trial could attract multiple potential acquirers in the second half of 2027 or even earlier. This acquisition potential adds another layer to the investment thesis.
Market Performance and Insider Signal
PLSE's significant stock move was entirely company-specific, as the S&P 500, Dow Jones, and Nasdaq all traded lower during the session. The rally pushed the stock toward its 52-week high of $58.90, a substantial gain from its 52-week low of $12.56.
Adding to investor confidence was a recent open-market share purchase by the company's COO in early September. Such insider buying is often interpreted by the market as a strong signal of internal conviction in a company's future prospects.
Read next
More on Stocks
FTC Orders Walmart, Uber, Delta to Disclose Data on Personalized Pricing
The U.S. Federal Trade Commission is demanding nine major companies, including leading retail, travel, and gig economy firms, to provide information on how they use consumer data for setting individual prices and wages.
Google Launches Gemini 4 Carbon AI Model to Bolster Cybersecurity Capabilities
Alphabet's Google has unveiled Gemini 4 Carbon, its latest AI model specifically designed for advanced cybersecurity tasks like vulnerability detection and secure code generation. The launch escalates competition with rivals OpenAI and Anthropic in the enterprise AI market.
Oracle Shares Surge After Unveiling $225 Billion Revenue Target for 2030
Oracle stock rose sharply after the company presented a long-term financial outlook targeting at least $225 billion in annual revenue by fiscal 2030, driven by its expanding AI infrastructure business.
DOJ Scrutinizes Nvidia's $12.9B Hugging Face Deal Amid Broader Antitrust Probe, Sources Say
The U.S. Department of Justice is reportedly examining Nvidia's planned $12.93 billion acquisition of AI platform Hugging Face as part of a wider, ongoing antitrust investigation into the chipmaker's market conduct.